# Melittin (Bee Venom)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/melittin
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-25
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Apis mellifera venom peptide, Bee venom peptide, BVP, Honeybee toxin, Melittin peptide, Apis venom melittin

## Overview

Melittin is the primary bioactive peptide in bee venom, comprising approximately 50% of its dry weight and consisting of 26 amino acids. It exerts its effects by directly inserting into phospholipid bilayers to form pores, disrupting cell membrane integrity and triggering downstream [inflammatory](/ingredients/condition/inflammation) and cytotoxic cascades.

## Health Benefits

• Pain modulation research - primarily studied as a pain-inducing agent in preclinical models, not as a therapeutic
• Potential antidiabetic effects - animal models show glucose and lipid-lowering properties (no human data)
• Cell membrane interaction - demonstrates pore-forming properties in laboratory studies
• Enzyme modulation - inhibits various kinases and ATPases in preclinical research
• Anti-[inflammatory pathway](/ingredients/condition/inflammation) activation - triggers cytokine release in experimental settings (paradoxically pro-inflammatory)

## Mechanism of Action

Melittin integrates into lipid bilayers via its amphipathic alpha-helical structure, forming toroidal pores that disrupt membrane potential and allow ion flux, particularly calcium influx, which activates phospholipase A2 and arachidonic acid release. This cascade stimulates prostaglandin and leukotriene synthesis, contributing to both its pain-inducing and [anti-inflammatory](/ingredients/condition/inflammation) paradoxical effects depending on dose and context. At the receptor level, melittin activates TRPV1 and TRPA1 nociceptors and modulates NF-κB signaling, which underlies its studied antidiabetic and anticancer properties in preclinical models.

## Clinical Summary

The overwhelming body of melittin research is preclinical, conducted in vitro or in rodent models, with virtually no controlled human clinical trials evaluating purified melittin as a therapeutic agent. In diabetic mouse models, bee venom containing melittin reduced fasting [blood glucose](/ingredients/condition/weight-management) by up to 30% and improved lipid profiles, though the contribution of melittin specifically versus other venom components was not isolated. Whole bee venom acupuncture (apitherapy) has been studied in small human trials of 20–50 participants for conditions like Parkinson's disease and musculoskeletal pain, but these studies cannot be attributed solely to melittin and carry high risk of bias. Current evidence is insufficient to support any therapeutic dosing recommendations for isolated melittin in humans.

## Nutritional Profile

Melittin is a 26-amino acid amphipathic peptide (molecular weight ~2,846 Da), not a nutritional ingredient. It constitutes approximately 40-50% of dry bee venom by weight. Amino acid composition includes glycine, isoleucine, leucine, lysine, alanine, valine, tryptophan, proline, and threonine as primary residues; notably rich in hydrophobic residues (~50% of sequence) with a strongly cationic C-terminus due to lysine clustering. It contains no vitamins, dietary minerals, fiber, or conventional macronutrients in any meaningful nutritional sense. As a bioactive peptide, it is typically encountered in microgram quantities per bee sting (approximately 2-8 mcg per sting, with a full venom injection estimated at 50-140 mcg total venom containing ~20-70 mcg melittin). Bioavailability via oral route is extremely poor due to rapid proteolytic degradation in the gastrointestinal tract; injectable or transdermal routes are used in research. Key bioactive properties are structural: the N-terminal hydrophobic helix (residues 1-20) inserts into lipid bilayers, while the C-terminal segment (residues 21-26) carries a net +6 charge at physiological pH, driving membrane pore formation. No caloric, mineral, or vitamin contribution is applicable.

## Dosage & Preparation

No clinically studied dosage ranges exist for melittin supplements as no human trials have been conducted. The compound's documented toxicity and harmful classification (H302, H312) suggest extreme caution is needed. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Melittin is a potent cytotoxin and hemolytic agent that lyses red blood cells at low micromolar concentrations, making systemic administration acutely dangerous without targeted drug delivery systems. The most critical risk is anaphylaxis; bee venom allergy affects approximately 3% of the population and can be fatal without immediate epinephrine administration. Melittin may potentiate the effects of anticoagulants such as warfarin and NSAIDs due to phospholipase A2 activation and platelet disruption, and it is absolutely contraindicated in individuals with known hymenoptera venom allergy. Safety during pregnancy and lactation has not been established in any controlled study, and use should be avoided entirely in these populations.

## Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses for melittin were found in the research dossier. All evidence comes from preclinical animal models and in-vitro studies, with no PubMed PMIDs for human studies provided.

## Historical & Cultural Context

The research provides no information on traditional medicinal uses of melittin. Its primary natural function is as a defensive toxin in honeybee venom to cause pain and tissue damage to hive intruders.

## Synergistic Combinations

No synergistic ingredients identified in research

## Frequently Asked Questions

### Is melittin from bee venom safe to take as a supplement?

Isolated melittin is not considered safe for unsupervised supplemental use due to its potent hemolytic and cytotoxic properties at systemic concentrations. Even in therapeutic research, melittin must be encapsulated in nanoparticles or conjugated to targeting molecules to prevent indiscriminate cell membrane destruction. Individuals with bee venom allergies face life-threatening anaphylaxis risk from any bee venom exposure.

### What does melittin actually do in the body?

Melittin inserts into cell membranes and forms pores, causing uncontrolled ion flux — particularly calcium entry — that activates phospholipase A2 and triggers arachidonic acid-driven inflammation. At low doses it can paradoxically modulate immune signaling via NF-κB inhibition, which is why it is studied for anti-inflammatory applications. At higher doses it causes cell lysis, making dose precision critical in any research context.

### Can melittin or bee venom help with diabetes?

In streptozotocin-induced diabetic mouse models, bee venom administration reduced fasting blood glucose levels by approximately 25–30% and lowered triglycerides, with effects partially attributed to melittin's influence on AMPK activation and insulin signaling pathways. However, no human randomized controlled trials have tested isolated melittin for diabetes management, and the risk-benefit profile of bee venom in humans does not currently support this use. These findings should not be extrapolated to human supplementation.

### How is melittin different from whole bee venom?

Whole bee venom is a complex mixture containing melittin (roughly 50% dry weight), apamin, phospholipase A2, histamine, adolapin, and hyaluronidase, among other compounds. Melittin is the primary membrane-disrupting and hemolytic agent, while phospholipase A2 synergizes with it to amplify cell membrane damage. Apitherapy studies use whole venom, making it scientifically inaccurate to attribute observed effects exclusively to melittin.

### Is melittin being studied as a cancer treatment?

Yes, melittin is actively researched as an anticancer agent because its pore-forming ability can preferentially disrupt cancer cell membranes, particularly when conjugated to tumor-targeting peptides or loaded into nanoparticle delivery systems. In vitro studies have shown melittin-induced apoptosis in breast, liver, and prostate cancer cell lines via cytochrome c release and caspase-3 activation. However, all anticancer research remains at the preclinical stage as of 2024, and no melittin-based cancer therapy has received regulatory approval.

### What is the difference between melittin derived from bee venom and other bee-derived supplements like propolis or royal jelly?

Melittin is a specific peptide compound that comprises approximately 40-50% of bee venom by dry weight, whereas propolis and royal jelly are different bee products with entirely different compositions and mechanisms of action. Propolis is a resinous mixture collected by bees from plants, while royal jelly is a nutritious secretion produced by worker bees—neither contains significant melittin. These supplements target different biological pathways and have distinct research profiles, with melittin being primarily studied for its effects on cell membranes and pain responses rather than immune support or nutrient density.

### Does melittin from bee venom have drug interactions with common medications?

Limited human studies exist on melittin's interactions with medications, making definitive safety conclusions difficult; however, its known effects on ion channels, cell membranes, and enzyme systems suggest potential interactions with anticoagulants, antiplatelet agents, or immunosuppressants warrant caution. Anyone taking prescription medications, particularly those affecting blood clotting or immune function, should consult a healthcare provider before using melittin supplements. Most interaction data comes from preclinical research rather than controlled human trials.

### Why is melittin studied mainly as a pain-inducing agent rather than as a pain reliever in research?

Melittin's primary mechanism in preclinical studies involves activating nociceptors (pain-sensing nerve endings) through its pore-forming properties in cell membranes, making it a useful research tool for understanding pain pathways rather than treating pain itself. Researchers use melittin in animal models to induce controlled pain responses and test potential analgesic compounds, but this doesn't translate directly to therapeutic pain management in humans. The distinction is important because melittin's known biological activity in these models suggests it would more likely cause pain sensation rather than relieve it in human subjects.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*